Skip to main content
TCMD logo

TCMD · Tactile Systems Technology Inc

Track TCMD — free
$21.87 -0.14 (-0.64%) At close · Sep 4
Market Cap
$495.41M
Shares
22.65M

TCMD metrics

93 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.87
Market cap
$495.41M

Price action

19 metrics
Price change (1W)
-5.6%
Price change (30D)
-24.9%
Price change (3M)
-13.9%
Price change (6M)
-24.1%
Price change (YTD)
-24.6%
Price change (1Y)
+63.0%
Trailing year
Price change (5Y)
-49.0%
52-week high
$33.05
52-week low
$13.26
Change from 52-week high
-33.8%
Change from 52-week low
+64.9%
Annualized volatility
63.3%
Beta
0.8
RSI (14D)
29.1
Price vs SMA 50
-19.0%
Price vs SMA 200
-18.7%
Avg volume (3M)
288,495
Relative volume
0.7
Average dollar volume
$7.65M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
22.65M

Valuation

12 metrics
P / E (TTM)
20.4
Trailing earnings · reciprocal yield 4.9%
PEG ratio
0.1
EV / revenue
1.2×
reciprocal yield 82.3%
EV / EBITDA
10.2×
reciprocal yield 9.8%
EV / EBIT
12.1×
reciprocal yield 8.2%
P / sales
1.4×
reciprocal yield 70.7%
P / book
2.2
reciprocal yield 45.2%
FCF yield
5.4%
TTM · current market cap
Buyback yield
1.3%
P / FCF
18.5
reciprocal yield 5.4%
P / operating cash flow
16.2
reciprocal yield 6.2%
Earnings yield
5.0%

Historical valuation

8 metrics
P / E historical average (3Y)
22.7×
reciprocal yield 4.4%
P / E historical average (5Y)
96.1×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
1.1×
reciprocal yield 89.6%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 83.0%
EV / EBIT historical average (3Y)
14.6×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
22.0×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
10.6×
reciprocal yield 9.4%
EV / EBITDA historical average (5Y)
20.8×
reciprocal yield 4.8%

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
1.3%
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
76.8%
Operating margin
10.0%
Trailing 12 months
Net margin
7.1%
Gross profit (TTM)
$268.97M
Operating profit (TTM)
$35.03M
Net income (TTM)
$24.86M
Trailing 12 months
Diluted EPS (TTM)
$1.07
FCF margin
7.7%
Effective tax rate
33.4%

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$-1.75

Growth

11 metrics
Revenue growth YoY
+8.6%
Year over year
Net income growth YoY
+142.0%
Revenue (TTM)
$350.31M
Trailing 12 months
EPS growth YoY
+142.9%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.1%
Revenue CAGR (5Y)
+12.0%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
+127.6%
FCF CAGR (5Y)
+122.9%

Quality

14 metrics
Return on equity
11.1%
Return on assets
8.9%
Debt / equity
0.0
Current ratio
4.1
EBITDA (TTM)
$41.74M
Free cash flow (TTM)
$26.82M
Quick ratio
3.7
Interest coverage
139.6
Net debt / EBITDA
-1.7
Return on invested capital
15.1%
Trailing 12 months
Net cash
$69.85M
Latest balance sheet
Cash & equivalents
$69.85M
Total assets
$279.67M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$30.55M
Capital expenditures (TTM)
$3.73M
R&D (TTM)
$10.00M
SG&A (TTM)
Stock compensation (TTM)
$8.39M
R&D / revenue
2.9%
Stock compensation / revenue
2.4%

Ownership (13F)

3 metrics
13F filers
181
13F filer change QoQ
-5
Institutional ownership
96.8%

Short interest

3 metrics
Short interest
11.3%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$323,243
Insider-sentiment score
40 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1027838 CUSIP 87357P100 13F (30d) 121 filings 121 filers Visit website Investor relations